| Literature DB >> 35013847 |
Jad A Elharake1,2, Faris Akbar3,4, Amyn A Malik3,5, Walter Gilliam6, Saad B Omer3,5,7,8.
Abstract
The COVID-19 pandemic led to a worldwide lockdown and school closures, which have placed a substantial mental health burden on children and college students. Through a systematic search of the literature on PubMed and Collabovid of studies published January 2020-July 2021, our findings of five studies on children and 16 studies on college students found that both groups reported feeling more anxious, depressed, fatigued, and distressed than prior to the pandemic. Several risk factors such as living in rural areas, low family socioeconomic status, and being a family member or friend to a healthcare worker were strongly associated with worse mental health outcomes. As schools and researchers discuss future strategies on how to combine on-site teaching with online courses, our results indicate the importance of considering social contacts in students' mental health to support students at higher risk of social isolation during the COVID-19 pandemic.Entities:
Keywords: Depression; Education; Mental health; Public health; School children
Year: 2022 PMID: 35013847 PMCID: PMC8747859 DOI: 10.1007/s10578-021-01297-1
Source DB: PubMed Journal: Child Psychiatry Hum Dev ISSN: 0009-398X
Fig. 1Systematic review of studies on COVID-19 impact on child mental health
COVID-19 Child-related Mental Health Studies
| Authors | Publication Status | Study Type | Country | Data Collection Timeline | Total (N) | Gender | Age Range | Parent Education | Child Education | Parents work as Healthcare Workers | Worried and concerned about COVID-19 | Region | Depression | Anxiety | The Spence Child Anxiety Scale (SCAS) Score | Post-Traumatic Stress Disorder (PTSD) | Stress |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chen et al | Peer-reviewed | Cross-sectional | China | April 16 to April 23, 2020 | 1036 | Male: 531 (51%) Female: 505 (49%) | 6–8 years old: 343 (33%) 9–12 years old: 310 (30%) 13–15 years old: 383 (37%) | Primary education and below: 155 (8%) Secondary education level: 734 (35%) University education level and above: 1183 (57%) | N/A | 58 (5.6%) | N/A | N/A | Yes: 112 (11.78%) | Yes: 196 (18.9%) | N/A | N/A | N/A |
| Duan et al | Peer-reviewed | Cross-sectional | China | N/A | 3613 | Male: 1812 (50%) Female: 1801 (50%) | 7–12 years old: 359 (10%) 13–18 years old: 3254 (90%) | N/A | Primary school: 218 (6%) Secondary school-fresh: 1949 (54%) Secondary school-repeated: 54 (1.5%) High school-fresh: 1374 (38%) High school-repeated: 18 (0.5%) | Father only: 57 (2%) Mother only: 47 (1%) Both parents: 37 (1%) Relatives 32: (1%) None: 3443 (95%) | Very concerned: 2109 (58%) Concerned: 1181 (33%) Average: 300 (8%) Not concerned 15 (~ 0%) Very unconcerned: 8 (~ 0%) | Urban: 1799 (50%) Rural: 1814 (50%) | Yes: 795 (22%) | N/A | Male: 21.68 ± 14.76 Female: 25.88 ± 16.47 Overall: 23.87 ± 15.79 Male: 25.56 ± 19.32 Female: 33.09 ± 19.54 Overall: 29.27 ± 19.79 | N/A | N/A |
| Liang et al | Peer-reviewed | Cross-sectional | China | N/A | 584 | Male: 223 (38%) Female: 361 (62%) | 14–20 years old: 130 (22.3%) 21–30 years old: 436 (74.6%) 31–35 years old: 18 (3.1%) | N/A | Junior high school or below: 18 (3.1%) High school or secondary school: 32 (5.5%) Undergraduate or college: 455 (77.9%) Master’s degree or above: 79 (13.5%) | N/A | N/A | N/A | N/A | N/A | N/A | Female: 26.74 ± 8.89 Male: 29.27 ± 13.58 | N/A |
| Xie et al | Peer-reviewed | Cross-sectional | China | February 28 to March 5, 2020 | 1784 | Male: 1012 (56.7%) Female: 772 (43.3%) | N/A | N/A | Grade 2: 373 (20.9%) Grade 3: 329 (18.4%) Grade 4: 406 (22.8%) Grade 5: 298 (16.7%) Grade 6: 378 (21.2%) | N/A | Quite worried: 665 (37.3%) Moderately worried: 445 (24.9%) Slightly or not worried: 674 (37.8%) Quite optimistic: 908 (50.9%) Moderately optimistic: 665 (37.3%) Not optimistic: 211 (11.8%) | N/A | Depressive symptoms: 403 (22.6%) | Anxiety symptoms: 337 (18.9%) | N/A | N/A | N/A |
| Tang et al | Peer-reviewed | Cross-sectional | China | March 13–23, 2020 | 4342 | Male: 2216 (51%) Female: 2126 (49%) | N/A | N/A | Primary school: 996 (22.9%) Junior secondary school: 3023 (69.6%) Senior secondary school: 323 (7.4%) | N/A | N/A | Depressive symptoms: 855 (19.7%) | Anxiety symptoms: 1081 (24.9%) | N/A | N/A | Stress symptoms: 660 (15.2%) |
Fig. 2Systematic review of studies on COVID-19 impact on college student mental health
COVID-19 College Student-related Mental Health Studies
| Author | Publication Status | Study Type | Country | Data Collection Timeline | Total (N) | Gender | Anxiety | Depression | Stress | General Health Questionnaire -12 (GHQ-12) | Post-Traumatic Stress Disorder (PTSD) | Negative Coping | Post-Traumatic Growth | Suicidal Thoughts | Depressive Thoughts | Crying Spells/ Losing Control | Feeling Fatigued | Feeling Sad and Empty |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liang et al | Peer-reviewed | Cross-sectional | China | N/A | 584 | Male: 223 (38%) Female: 361 (62%) | N/A | N/A | N/A | Female: 11.55 ± 6.14 Male: 12.85 ± 6.66 | Female: 26.74 ± 8.89 Male: 29.27 ± 13.58 | Female: 19.15 ± 5.00 Male: 20.44 ± 6.05 | N/A | N/A | N/A | N/A | N/A | N/A |
| Son et al | Peer-reviewed | Cross-sectional | United States | April 2020 | 195 | Male: 84 (43%) Female: 111 (57%) | Anxiety level increased: 138 (71%) Anxiety level remained the same: 39 (20%) Anxiety level decreased: 18 (9%) | N/A | Stress level increased: 138 (71%) Stress level remained the same: 39 (20%) Stress level decreased: 18 (9%) | N/A | N/A | N/A | N/A | None: 179 (92%) Mild: 10 (5%) Moderate: 6 (3%) Severe: 0 (0%) | None: 109 (56%) Mild: 57 (29%) Moderate: 19 (10%) Severe: 10 (5%) | N/A | N/A | N/A |
| Wang et al | Peer-reviewed | Cross-sectional | China | January 31 to February 5, 2020 | 44,447 | Male: 20,217 (45.5%) Female: 24,230 (54.5%) | Experienced Anxiety: 3434 (7.7%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Elmer et al | Peer-reviewed | Cohort | Switzerland | Cohort 1: 2016–2019 Cohorts 2 & 3: 2017–2020 | Total: 336 Cohort 1: 54 Cohort 2: 86 Cohort 3: 196 | Male: 33 (61%) Female: 21 (38.9%) Male: 57 (62%) Female: 29 (38%) Male: 166 (85%) Female: 30 (15%) | Those assessed during the pandemic were more anxious (Mdiff = 0.60, SE = 0.24, t (208) = 2.47, p = .014, d = .10) | Those assessed during the pandemic were more depressed (Mdiff = 4.44, SE = 0.50, t (208) = 8.89, p < .001, d = .34) | Those assessed during the pandemic were more stressed (Mdiff = 2.67, SE = 0.40, t (208) = 6.64, p < .001, d = .23) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Chi et al | Peer-reviewed | Cross-sectional | China | February 12–17, 2020 | 2038 | Male: 755 (37%) Female: 1283 (63%) | Experienced anxiety: (15%) | Experienced depression: (23.3%) | N/A | N/A | 628 (30.8%) reported having PTSD | N/A | 1363 (66.9%) reported having post-traumatic growth | N/A | N/A | N/A | N/A | N/A |
| Naser et al | Peer-reviewed | Cross-sectional | Jordan | March 22–28, 2020 | 1165 | Female: 627 (54%) Male: 538 (46%) | Mild anxiety: 394 (33.8%) Moderate anxiety: 284 (24.4%) Severe anxiety: 250 (21.5%) | Minimal depression: 148 (12.7%) Mild depression: 302 (25.9%) Moderate depression: 266 (22.8%) Moderately severe depression: 236 (20.3%) Severe depression 213 (18.3%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sun et al | Non-peer reviewed | Cross-sectional | China | March 20 to April 10 2020 | 1912 | Female: 1334 (59%) Male: 578 (41%) | No symptoms: 1248 (65.27%) Mild symptoms: 480 (25.10%) Moderate symptoms: 158 (8.26%) Severe symptoms: 26 (1.36%) | No symptoms: 1022 (53.45%) Mild symptoms: 592 (30.96%) Moderate symptoms: 169 (8.84%) Moderately severe: 102 (5.33%) Severe symptoms: 27 (1.41%) | N/A | N/A | No symptoms: 630 (32.95%) Mild symptoms 944 (49.37%) Moderate symptoms: 119 (6.22%) Severe symptoms: 219 (11.45%) | N/A | N/A | Never: 1538 (80%) Rarely: 261 (14%) Sometimes: 93 (5%) Often: 20 (1%) | N/A | N/A | N/A | N/A |
| Ojewale | Non-peer reviewed | Cross-sectional | Nigeria | N/A | 386 | Female: 232 (60%) Male: 154 (40%) | Normal: 226 (58.5%) Mild: 80 (20.7%) Moderate: 65 (16.8%) Severe: 15 (3.9%) | Normal: 263 (68.1%) Mild: 81 (21%) Moderate: 32 (8.3%) Severe: 10 (2.6%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Moghe et al | Non-peer reviewed | Cross-sectional | India | June 23 to June 30, 2020 | 351 | Female: 162 (46%) Male: 186 (53%) Prefer not to say: 3 (0%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Female: 122 (34.9%) Male: 124 (35.3%) | Female: 123 (35.1%) Male: 124 (35.3%) | Female: 151 (42.9%) Male: 147 (41.8%) |
| Chang et al | Peer-reviewed | Cross-sectional | China | January 31, 2019 to February 3, 2020 | 3881 | Male: 1434 (37%) Female: 2447 (63%) | Mild: 900 (23.19%) Moderate: 105 (2.71%) Severe: 27 (0.7%) | Mild: 659 (16.98%) Moderate: 123 (3.17%) Severe: 39 (1.01%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Wang et al | Peer-reviewed | Cross-sectional | United States | May 4 to May 19, 2020 | 2031 | Male: 757 (37%) Female: 1252 (63%) | None: 616 (30%) Mild: 670 (33%) Moderate: 447 (22%) Severe: 298 (15%) | Mild: 647 (32%) Moderate: 496 (24%) Moderately severe: 316 (15%) Severe: 148 (7%) | Stress levels increased: 1143 (56%) | N/A | N/A | N/A | N/A | None: 1695 (83.44%) Mild: 213 (10.53%) Moderate: 84 (4.12%) Severe: 39 (1.91%) | None: 677 (33.33%) Mild: 717 (35.29%) Moderate: 469 (20.31%) Severe: 225 (11.06%) | N/A | N/A | N/A |
| Cao et al | Peer-reviewed | Cross-sectional | China | N/A | 7143 | Male: 2168 (30%) Female: 4975 (70%) | Normal: 5367 (75.1%) Mild: 1518 (21.4%) Moderate: 196 (2.7%) Severe: 62 (0.8%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fu et al | Peer-Reviewed | Cross-sectional | China | May 10 to June 10, 2020 | 89,588 | Male: 39,194 (44%) Female: 50,394 (56%) | Symptoms: 36,865 (41.1%) No symptoms: 52,723 (58.9%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Rudenstine et al | Peer-reviewed | Cross-sectional | United States | April 8 to May 2 2020 | 1821 | Male: 493 (27.1%) Female: 1301 (71.6%) | Symptoms: 752 (41.3%) No symptoms: 1069 (58.7%) | Symptoms: 916 (50.3%) No symptoms: 905 (49.7%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Ma et al | Peer-reviewed | Cross-sectional | China | February 3–10, 2020 | 746,217 | Male: 331,613 (44.4%) Female: 414,604 (55.6%) | 82,084 (11%) | 157,452 (21.1%) | 26,600 (34.9%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Wathelet et al | Peer-reviewed | Cross-sectional | France | April 17 to May 4, 2020 | 69,054 | Male: 18,019 (26%) Female: 50,251 (73%) | 18,990 (27.5%) | 11,118 (16.1%) | 17,056 (24.7%) | N/A | N/A | N/A | N/A | 7872 (11.4%) | N/A | N/A | N/A | N/A |